OM DENNE EPISODE
Semaglutide, the ingredient behind weekly injections for diabetes and weight management, lost its main patent in India this year, and a dozen or so companies launched their own versions almost overnight. The seventh episode of Pharma Explained looks at what has changed for prices, brands and patients, and how the same patent expiry is playing out in other countries.
We’ll cover:
- How the generic launch has changed what patients can buy and what it costs.
- How the original makers have responded.
- What it could mean for patient safety, daily life and your wallet.
- How Brazil, Canada and China compare with India.
- What we still don’t know, including how many patients will stay on treatment.
For the detailed stories, with sources and full numbers, visit the Pharma Now website and mobile app.
Follow Pharma Now’s social handles:
- LinkedIn: https://www.linkedin.com/company/pharma-now/?viewAsMember=true
- Facebook: https://www.facebook.com/profile.php?id=61559659700692
- X: https://x.com/PharmaNowGlobal
- Instagram: https://www.instagram.com/pharmanow.live/
Note: This content is for informational purposes only and is not medical advice. Talk to your doctor or pharmacist about your own treatment. None of the companies or products mentioned are recommendations or endorsements.
Engelsk
USA
UDSKRIFT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SØK BLANT TIDLIGERE EPISODER
Søk etter gamle episoder av Pharma Explained.
ANDRE EPISODE I DENNE PODKAST
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!
In this episode of Pharma Explained, by Pharma Now, we look at a cancer vaccine that is made from each patient’s own tumour and has just passed its biggest test so far. We explain how a vaccine …
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!
In this episode of Pharma Explained, by Pharma Now, we ask whether the United States is about to lose a public health title it has held for 25 years. An expert commission of the Pan American Hea…
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!
In this episode of Pharma Explained, by Pharma Now, we look at an Ebola outbreak in the Democratic Republic of the Congo caused by a strain that has no approved vaccine or treatment made for it.…
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!
In this episode of Pharma Explained, by Pharma Now, we look at an antibiotic that, according to its maker Wockhardt, is the first new medicine fully discovered and developed by an Indian company…
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!
In this episode of Pharma Explained, we look at a draft rule from China that could stop its companies from selling the core toolkits behind some of the newest medicines to foreign buyers. These …
Ansvarsfraskrivelse: Podkasten og kunstværket, det finnes indlejret på denne siden, er fra Pharma Now, som tilhører dens eier og ikke er tilknyttet eller godkjent av Listen Notes, Inc.
REDIG
Takk fordi du hjelper med å holde podkast-databasen oppdatert.